Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,922 GBX | +0.44% | +5.50% | +7.21% |
Apr. 26 | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.21% | 5.29B | |
+25.83% | 661B | |
+27.52% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+15.11% | 231B | |
+5.29% | 200B | |
-9.53% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- RBC Raises Hikma Pharmaceuticals PT, Affirms Sector Perform Rating